FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to organic chemistry, namely to a compound of formula (I) and its isomers, using them for treating a condition associated with P2X3 activity, to a pharmaceutical composition based on the compound of formula (I) or its isomers, and to a method of treating.
EFFECT: what is prepared is the new heterocyclic compound possessing the effective biological properties.
16 cl, 1 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
IMIDAZOPYRIDINE COMPOUNDS USEFUL IN TREATMENT OF CONDITION ASSOCIATED WITH P2X3 AND/OR P2X2/3 ACTIVITY | 2014 |
|
RU2656593C2 |
NICOTINIC RECEPTOR LIGANDS | 2007 |
|
RU2441007C2 |
MORPHOLINYL PYRIDONES | 2018 |
|
RU2803158C2 |
METHOD OF TREATMENT OF PERACUTE, CHRONIC AND SUBACUTE COUGH AND IRRESISTIBLE DESIRE TO CLEAR THROAT | 2014 |
|
RU2650118C2 |
THERAPEUTIC AGENTS 713 | 2010 |
|
RU2526055C2 |
COMPOUNDS 6,7-DIHYDRO-5H-PYRAZOLO[5,1-B][1,3]OXAZINE-2-CARBOXAMIDE | 2017 |
|
RU2719599C2 |
QUINOLINE CARBOXAMIDE AND QUINOLINE CARBONITRILE DERIVATIVES AS mGluR2 NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS AND USE THEREOF | 2012 |
|
RU2610262C2 |
NEW HYDANTOIC DERIVATIVES FOR TREATING OBSTRUCTIVE AIRWAY DISEASES | 2005 |
|
RU2386629C2 |
NOVEL HYDANTOIN DERIVATIVES AS METALLOPROTEINASE INHIBITORS | 2005 |
|
RU2378269C2 |
DIHYDROPYRIMIDIN COMPOUNDS AND THEIR APPLICATION IN PHARMACEUTICALS | 2015 |
|
RU2682672C2 |
Authors
Dates
2015-02-20—Published
2010-11-17—Filed